81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals stock buybacks 1991–2026What are stock buybacks? A stock buyback is a company buying its own shares on the market. With fewer shares left, each remaining share owns a bigger part of the company.
Vertex Pharmaceuticals spent 126.70M USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, down 88.2% on the same quarter a year before. Vertex Pharmaceuticals spent 1.30B USD buying back its shares over the last twelve months, down 43.8% on the twelve months before. In fiscal year 2025 it spent 2.02B USD, up 71.4% on the year before.
Last updated 9 Nov 2026 · Next report 11 Feb 2027
Stock buybacks
Growth
| Fiscal year | Period ending | Stock buybacks | Growth | Dividends paid | Free cash flow |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 1.30B | -43.79% | — | 3.20B |
| FY2025 | 31 Dec 2025 | 2.02B | +71.39% | 0.00 | 3.19B |
| FY2024 | 31 Dec 2024 | 1.18B | +175.28% | 0.00 | -790.30M |
| FY2023 | 31 Dec 2023 | 427.60M | +148.60% | 0.00 | 3.28B |
| FY2022 | 31 Dec 2022 | 172.00M | -87.93% | 0.00 | 3.93B |
| FY2021 | 31 Dec 2021 | 1.43B | +164.39% | 0.00 | 2.41B |
| FY2020 | 31 Dec 2020 | 539.14M | +180.78% | 0.00 | 2.99B |
| FY2019 | 31 Dec 2019 | 192.02M | -45.15% | 0.00 | 1.49B |
| FY2018 | 31 Dec 2018 | 350.04M | — | 0.00 | 1.17B |
| FY2017 | 31 Dec 2017 | 0.00 | — | 0.00 | 585.52M |
| FY2016 | 31 Dec 2016 | 0.00 | — | 0.00 | 179.54M |
| FY2015 | 31 Dec 2015 | 0.00 | — | 0.00 | -410.73M |
| FY2014 | 31 Dec 2014 | 0.00 | — | 0.00 | -564.40M |
| FY2013 | 31 Dec 2013 | 0.00 | — | 0.00 | -102.96M |
| FY2012 | 31 Dec 2012 | 0.00 | — | 0.00 | 196.70M |
| FY2011 | 31 Dec 2011 | 0.00 | — | 0.00 | 49.14M |
| FY2010 | 31 Dec 2010 | 0.00 | — | 0.00 | -673.50M |
| FY2009 | 31 Dec 2009 | 0.00 | — | 0.00 | -451.08M |
| FY2008 | 31 Dec 2008 | 0.00 | — | 0.00 | -258.66M |
| FY2007 | 31 Dec 2007 | 0.00 | — | 0.00 | -284.89M |
| FY2006 | 31 Dec 2006 | 0.00 | — | 0.00 | -54.89M |
| FY2005 | 31 Dec 2005 | 0.00 | — | 0.00 | -189.01M |
| FY2004 | 31 Dec 2004 | 0.00 | — | 0.00 | -154.66M |
| FY2003 | 31 Dec 2003 | 0.00 | — | 0.00 | -184.97M |
| FY2002 | 31 Dec 2002 | 0.00 | — | 0.00 | -120.76M |
| FY2001 | 31 Dec 2001 | 0.00 | — | 0.00 | -61.97M |
| FY2000 | 31 Dec 2000 | 0.00 | — | 0.00 | -28.56M |
| FY1999 | 31 Dec 1999 | 0.00 | — | 0.00 | -48.00M |
| FY1998 | 31 Dec 1998 | 0.00 | — | 0.00 | -39.00M |
| FY1997 | 31 Dec 1997 | 0.00 | — | 0.00 | -15.40M |
| FY1996 | 31 Dec 1996 | 0.00 | — | 0.00 | -44.30M |
| FY1995 | 31 Dec 1995 | 0.00 | — | 0.00 | -21.40M |
| FY1994 | 31 Dec 1994 | 0.00 | — | 0.00 | -16.60M |
| FY1993 | 31 Dec 1993 | 0.00 | — | 0.00 | 6.80M |
| FY1992 | 31 Dec 1992 | 0.00 | — | 0.00 | -6.80M |
| FY1991 | 31 Dec 1991 | 0.00 | — | 0.00 | -3.70M |
| Quarter | Period ending | Stock buybacks | Growth on a year before | Dividends paid | Free cash flow |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 126.70M | -88.17% | 0.00 | 545.80M |
| Q2 FY2026 | 30 Jun 2026 | 473.80M | +20.93% | 0.00 | 1.01B |
| Q1 FY2026 | 31 Mar 2026 | 565.40M | +32.69% | 0.00 | 1.29B |
| Q4 FY2025 | 31 Dec 2025 | 130.90M | -68.68% | 0.00 | 348.60M |
| Q3 FY2025 | 30 Sept 2025 | 1.07B | +248.10% | 0.00 | 1.14B |
| Q2 FY2025 | 30 Jun 2025 | 391.80M | +22.32% | 0.00 | 927.40M |
| Q1 FY2025 | 31 Mar 2025 | 426.10M | +224.77% | 0.00 | 778.20M |
| Q4 FY2024 | 31 Dec 2024 | 417.90M | +179.53% | 0.00 | 492.00M |
| Q3 FY2024 | 30 Sept 2024 | 307.70M | +162.99% | 0.00 | 1.30B |
| Q2 FY2024 | 30 Jun 2024 | 320.30M | +1,031.80% | 0.00 | -3.83B |
| Q1 FY2024 | 31 Mar 2024 | 131.20M | -1.20% | 0.00 | 1.06B |
| Q4 FY2023 | 31 Dec 2023 | 149.50M | — | 0.00 | 176.50M |
| Q3 FY2023 | 30 Sept 2023 | 117.00M | — | 0.00 | 1.23B |
| Q2 FY2023 | 30 Jun 2023 | 28.30M | — | 0.00 | 1.07B |
| Q1 FY2023 | 31 Mar 2023 | 132.80M | — | 0.00 | 857.80M |
| Q4 FY2022 | 31 Dec 2022 | 0.00 | -100.00% | 0.00 | 1.04B |
| Q3 FY2022 | 30 Sept 2022 | 0.00 | -100.00% | 0.00 | 901.30M |
| Q2 FY2022 | 30 Jun 2022 | 0.00 | — | 0.00 | 1.09B |
| Q1 FY2022 | 31 Mar 2022 | 0.00 | -100.00% | 0.00 | 892.60M |
| Q4 FY2021 | 31 Dec 2021 | 368.18M | +180.83% | 0.00 | 933.19M |
| Q3 FY2021 | 30 Sept 2021 | 632.27M | +485.40% | 0.00 | 874.82M |
| Q2 FY2021 | 30 Jun 2021 | 0.00 | — | 0.00 | -249.67M |
| Q1 FY2021 | 31 Mar 2021 | 424.95M | +41.64% | 0.00 | 850.16M |
| Q4 FY2020 | 31 Dec 2020 | 131.10M | +263.55% | 0.00 | 443.84M |
| Q3 FY2020 | 30 Sept 2020 | 108.01M | +103,752.88% | 0.00 | 732.95M |
| Q2 FY2020 | 30 Jun 2020 | 0.00 | -100.00% | 0.00 | 1.02B |
| Q1 FY2020 | 31 Mar 2020 | 300.03M | +200.51% | 0.00 | 796.25M |
| Q4 FY2019 | 31 Dec 2019 | 36.06M | -74.78% | 0.00 | 429.25M |
| Q3 FY2019 | 30 Sept 2019 | 104.00K | -99.89% | 0.00 | 310.50M |
| Q2 FY2019 | 30 Jun 2019 | 56.01M | -46.67% | 0.00 | 447.39M |
| Q1 FY2019 | 31 Mar 2019 | 99.84M | +898.39% | 0.00 | 306.74M |
| Q4 FY2018 | 31 Dec 2018 | 143.01M | — | 0.00 | 298.86M |
| Q3 FY2018 | 30 Sept 2018 | 92.01M | — | 0.00 | 360.44M |
| Q2 FY2018 | 30 Jun 2018 | 105.03M | — | 0.00 | 292.09M |
| Q1 FY2018 | 31 Mar 2018 | 10.00M | — | 0.00 | 223.38M |
| Q4 FY2017 | 31 Dec 2017 | 0.00 | — | 0.00 | 184.91M |
| Q3 FY2017 | 30 Sept 2017 | 0.00 | — | 0.00 | -17.87M |
| Q2 FY2017 | 30 Jun 2017 | 0.00 | — | 0.00 | 163.95M |
| Q1 FY2017 | 31 Mar 2017 | 0.00 | — | 0.00 | 254.53M |
| Q4 FY2016 | 31 Dec 2016 | 0.00 | — | 0.00 | 129.94M |
| Q3 FY2016 | 30 Sept 2016 | 0.00 | — | 0.00 | 51.77M |
| Q2 FY2016 | 30 Jun 2016 | 0.00 | — | 0.00 | 24.94M |
| Q1 FY2016 | 31 Mar 2016 | 0.00 | — | 0.00 | -27.11M |
| Q4 FY2015 | 31 Dec 2015 | 0.00 | — | 0.00 | -28.54M |
| Q3 FY2015 | 30 Sept 2015 | 0.00 | — | 0.00 | -55.82M |
| Q2 FY2015 | 30 Jun 2015 | 0.00 | — | 0.00 | -108.63M |
| Q1 FY2015 | 31 Mar 2015 | 0.00 | — | 0.00 | -217.74M |
| Q4 FY2014 | 31 Dec 2014 | 0.00 | — | 0.00 | -136.55M |
| Q3 FY2014 | 30 Sept 2014 | 0.00 | — | 0.00 | -96.95M |
| Q2 FY2014 | 30 Jun 2014 | 0.00 | — | 0.00 | -139.62M |
| Q1 FY2014 | 31 Mar 2014 | 0.00 | — | 0.00 | -191.29M |
| Q4 FY2013 | 31 Dec 2013 | 0.00 | — | 0.00 | 14.38M |
| Q3 FY2013 | 30 Sept 2013 | 0.00 | — | 0.00 | -32.23M |
| Q2 FY2013 | 30 Jun 2013 | 0.00 | — | 0.00 | -2.73M |
| Q1 FY2013 | 31 Mar 2013 | 0.00 | — | 0.00 | -82.39M |
| Q4 FY2012 | 31 Dec 2012 | 0.00 | — | 0.00 | 12.51M |
| Q3 FY2012 | 30 Sept 2012 | 0.00 | — | 0.00 | 84.57M |
| Q2 FY2012 | 30 Jun 2012 | 0.00 | — | 0.00 | 102.86M |
| Q1 FY2012 | 31 Mar 2012 | 0.00 | — | 0.00 | -3.24M |
| Q4 FY2011 | 31 Dec 2011 | 0.00 | — | 0.00 | 494.33M |
| Q3 FY2011 | 30 Sept 2011 | 0.00 | — | 0.00 | 32.91M |
| Q2 FY2011 | 30 Jun 2011 | 0.00 | — | 0.00 | -286.63M |
| Q1 FY2011 | 31 Mar 2011 | 0.00 | — | 0.00 | -191.48M |
| Q4 FY2010 | 31 Dec 2010 | 0.00 | — | 0.00 | -180.53M |
| Q3 FY2010 | 30 Sept 2010 | 0.00 | — | 0.00 | -174.82M |
| Q2 FY2010 | 30 Jun 2010 | 0.00 | — | 0.00 | -118.57M |
| Q1 FY2010 | 31 Mar 2010 | 0.00 | — | 0.00 | -199.57M |
| Q4 FY2009 | 31 Dec 2009 | 0.00 | — | 0.00 | -109.91M |
| Q3 FY2009 | 30 Sept 2009 | 0.00 | — | 0.00 | -26.39M |
| Q2 FY2009 | 30 Jun 2009 | 0.00 | — | 0.00 | -122.65M |
| Q1 FY2009 | 31 Mar 2009 | 0.00 | — | 0.00 | -192.14M |
| Q4 FY2008 | 31 Dec 2008 | 0.00 | — | 0.00 | -103.84M |
| Q3 FY2008 | 30 Sept 2008 | 0.00 | — | 0.00 | -137.99M |
| Q2 FY2008 | 30 Jun 2008 | 0.00 | — | 0.00 | 94.19M |
| Q1 FY2008 | 31 Mar 2008 | 0.00 | — | 0.00 | -111.03M |
| Q4 FY2007 | 31 Dec 2007 | 0.00 | — | 0.00 | -57.89M |
| Q3 FY2007 | 30 Sept 2007 | 0.00 | — | 0.00 | -71.57M |
| Q2 FY2007 | 30 Jun 2007 | 0.00 | — | 0.00 | -81.49M |
| Q1 FY2007 | 31 Mar 2007 | 0.00 | — | 0.00 | -73.94M |
| Q4 FY2006 | 31 Dec 2006 | 0.00 | — | 0.00 | -11.48M |
| Q3 FY2006 | 30 Sept 2006 | 0.00 | — | 0.00 | 94.51M |
| Q2 FY2006 | 30 Jun 2006 | 0.00 | — | 0.00 | -69.76M |
| Q1 FY2006 | 31 Mar 2006 | 0.00 | — | 0.00 | -68.16M |
| Q4 FY2005 | 31 Dec 2005 | 0.00 | — | 0.00 | -12.15M |
| Q3 FY2005 | 30 Sept 2005 | 0.00 | — | 0.00 | -60.75M |
| Q2 FY2005 | 30 Jun 2005 | 0.00 | — | 0.00 | -58.05M |
| Q1 FY2005 | 31 Mar 2005 | 0.00 | — | 0.00 | -58.07M |
| Q4 FY2004 | 31 Dec 2004 | 0.00 | — | 0.00 | -27.45M |
| Q3 FY2004 | 30 Sept 2004 | 0.00 | — | 0.00 | -45.51M |
| Q2 FY2004 | 30 Jun 2004 | 0.00 | — | 0.00 | -26.96M |
| Q1 FY2004 | 31 Mar 2004 | 0.00 | — | 0.00 | -54.75M |
| Q4 FY2003 | 31 Dec 2003 | 0.00 | — | 0.00 | -32.55M |
| Q3 FY2003 | 30 Sept 2003 | 0.00 | — | 0.00 | — |
| Q2 FY2003 | 30 Jun 2003 | 0.00 | — | 0.00 | -48.26M |
| Q1 FY2003 | 31 Mar 2003 | 0.00 | — | 0.00 | -57.01M |
| Q4 FY2002 | 31 Dec 2002 | 0.00 | — | 0.00 | -24.04M |
| Q3 FY2002 | 30 Sept 2002 | 0.00 | — | 0.00 | -30.69M |
| Q2 FY2002 | 30 Jun 2002 | 0.00 | — | 0.00 | -25.94M |
| Q1 FY2002 | 31 Mar 2002 | 0.00 | — | 0.00 | -40.09M |
| Q4 FY2001 | 31 Dec 2001 | 0.00 | — | 0.00 | 30.53M |
| Q3 FY2001 | 30 Sept 2001 | 0.00 | — | 0.00 | -61.03M |
| Q2 FY2001 | 30 Jun 2001 | 0.00 | — | 0.00 | -12.90M |
| Q1 FY2001 | 31 Mar 2001 | 0.00 | — | 0.00 | -18.57M |
| Q4 FY2000 | 31 Dec 2000 | 0.00 | — | 0.00 | -19.63M |
| Q3 FY2000 | 30 Sept 2000 | 0.00 | — | 0.00 | -11.92M |
| Q2 FY2000 | 30 Jun 2000 | 0.00 | — | 0.00 | 21.20M |
| Q1 FY2000 | 31 Mar 2000 | 0.00 | — | 0.00 | -18.20M |
| Q4 FY1999 | 31 Dec 1999 | 0.00 | — | 0.00 | 6.50M |
| Q3 FY1999 | 30 Sept 1999 | 0.00 | — | 0.00 | -19.20M |
| Q2 FY1999 | 30 Jun 1999 | 0.00 | — | 0.00 | -17.90M |
| Q1 FY1999 | 31 Mar 1999 | 0.00 | — | 0.00 | -17.40M |
| Q4 FY1998 | 31 Dec 1998 | 0.00 | — | 0.00 | -13.00M |
| Q3 FY1998 | 30 Sept 1998 | 0.00 | — | 0.00 | -200.00K |
| Q2 FY1998 | 30 Jun 1998 | 0.00 | — | 0.00 | -11.40M |
| Q1 FY1998 | 31 Mar 1998 | 0.00 | — | 0.00 | -14.40M |
| Q4 FY1997 | 31 Dec 1997 | 0.00 | — | 0.00 | -5.40M |
| Q3 FY1997 | 30 Sept 1997 | 0.00 | — | 0.00 | -3.90M |
| Q2 FY1997 | 30 Jun 1997 | 0.00 | — | 0.00 | -1.10M |
| Q1 FY1997 | 31 Mar 1997 | 0.00 | — | 0.00 | -5.00M |
| Q4 FY1996 | 31 Dec 1996 | 0.00 | — | 0.00 | -5.20M |
| Q3 FY1996 | 30 Sept 1996 | 0.00 | — | 0.00 | -7.50M |
| Q2 FY1996 | 30 Jun 1996 | 0.00 | — | 0.00 | -22.70M |
| Q1 FY1996 | 31 Mar 1996 | 0.00 | — | 0.00 | -8.90M |
| Q4 FY1995 | 31 Dec 1995 | 0.00 | — | 0.00 | -3.40M |
| Q3 FY1995 | 30 Sept 1995 | 0.00 | — | 0.00 | -5.10M |
| Q2 FY1995 | 30 Jun 1995 | 0.00 | — | 0.00 | -7.40M |
| Q1 FY1995 | 31 Mar 1995 | 0.00 | — | 0.00 | -5.50M |
| Q4 FY1994 | 31 Dec 1994 | 0.00 | — | 0.00 | -5.80M |
| Q3 FY1994 | 30 Sept 1994 | 0.00 | — | 0.00 | -2.90M |
| Q2 FY1994 | 30 Jun 1994 | 0.00 | — | 0.00 | — |
| Q1 FY1994 | 31 Mar 1994 | 0.00 | — | 0.00 | -4.80M |
| Q4 FY1993 | 31 Dec 1993 | 0.00 | — | 0.00 | 10.00M |
| Q3 FY1993 | 30 Sept 1993 | 0.00 | — | 0.00 | -300.00K |
| Q2 FY1993 | 30 Jun 1993 | 0.00 | — | 0.00 | — |
| Q1 FY1993 | 31 Mar 1993 | 0.00 | — | 0.00 | -3.10M |
| Q4 FY1992 | 31 Dec 1992 | 0.00 | — | 0.00 | -2.70M |
| Q3 FY1992 | 30 Sept 1992 | 0.00 | — | 0.00 | — |
| Q2 FY1992 | 30 Jun 1992 | 0.00 | — | 0.00 | — |
| Q1 FY1992 | 31 Mar 1992 | 0.00 | — | 0.00 | -2.30M |
| Q4 FY1991 | 31 Dec 1991 | 0.00 | — | 0.00 | -1.00M |
| Q3 FY1991 | 30 Sept 1991 | 0.00 | — | 0.00 | -700.00K |
Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
The money spent buying back the company's own shares in each period, from the cash flow statement.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow
Common questions about Vertex Pharmaceuticals's buybacks
Source: Financial Modeling Prep